Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study

BACKGROUND: Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. METHODS AND FINDINGS: Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at the University of California San Diego conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Chambers, Christina D., Johnson, Diana L., Xu, Ronghui, Luo, Yunjun, Lopez-Jimenez, Janina, Adam, Margaret P., Braddock, Stephen R., Robinson, Luther K., Vaux, Keith, Lyons Jones, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799916/
https://www.ncbi.nlm.nih.gov/pubmed/31626646
http://dx.doi.org/10.1371/journal.pone.0223603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799916/
https://www.ncbi.nlm.nih.gov/pubmed/31626646
http://dx.doi.org/10.1371/journal.pone.0223603

Ejemplares similares